Pharma Bro Shkreli convicted of US securities fraud Ruby Khatun Khatun6 Aug 2017 9:14 AM ISTNew York: A US jury convicted former hedge fund manager and pharmaceutical executive Martin Shkreli, once dubbed "The Most Hated Man in America," of...
Narayana Hrudayalaya Q1 net profit slips 36% to Rs 11 crore Ruby Khatun Khatun5 Aug 2017 9:30 AM ISTMumbai: Narayana Hrudayalaya Ltd reported a 36 per cent decline in net profit at Rs 10.9 crore in the first quarter ended June 30 from Rs 17.2 crore...
FDA Approves Long-acting Injectable for Bipolar Disorder Ruby Khatun Khatun5 Aug 2017 9:20 AM ISTValby, Denmark and Tokyo, Japan: Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced Abilify Maintena®(aripiprazole) for...
Lupin gets USFDA nod for cholesterol-lowering drug Ruby Khatun Khatun5 Aug 2017 9:18 AM ISTNew Delhi: Drug firm Lupin on Thursday said it has received final approval from the US health regulator to market its Rosuvastatin Calcium tablets...
Biocon Q1 net profit slumps 51 percent to Rs 81 crore Ruby Khatun Khatun5 Aug 2017 9:16 AM ISTNew Delhi: Bio-pharmaceutical firm Biocon reported a 51.20 per cent decline in its consolidated net profit to Rs 81.3 crore for the quarter ended...
AstraZeneca gets breakthrough status for blood cancer drug Ruby Khatun Khatun5 Aug 2017 9:15 AM ISTLONDON: AstraZeneca said that U.S. regulators had awarded its blood cancer drug acalabrutinib "breakthrough" status for the treatment of patients with...
Johnson & Johnson arthritis drug sirukumab raises safety concerns: FDA staff Ruby Khatun Khatun5 Aug 2017 9:15 AM ISTThere were more deaths in patients taking Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab than among those taking a placebo,...
Daiichi Sankyo settles US lawsuits over blood pressure drug Benicar Ruby Khatun Khatun5 Aug 2017 9:14 AM ISTNew York: Daiichi Sankyo on Tuesday said it has agreed to pay up to $300 million to settle some 2,300 U.S. cases accusing the Japanese drugmaker of...
FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia Ruby Khatun Khatun4 Aug 2017 9:25 AM ISTThe U.S. Food and Drug Administration (FDA) approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid...
USFDA gives final nod to Glenmark Pharma for anti-herpes drug Ruby Khatun Khatun4 Aug 2017 9:20 AM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for Acyclovir Ointment used for treatment of herpes...
Several Researches are ongoing for Developing New Drugs in AYUSH: Shri Shripad Naik Ruby Khatun Khatun4 Aug 2017 9:18 AM ISTIn an statement while giving written reply to a question in Lok Sabha, Minister of State (Independent Charge) for AYUSH, Shri Shripad Naik said...
PNB ties up with Religare Health Insurance Ruby Khatun Khatun4 Aug 2017 9:16 AM ISTChennai: Religare Health Insurance announced its Bancassurance tie-up with one of the country's leading and largest banks – Punjab National Bank...
